Related Experiment Video
Updated: Mar 15, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
DDR2-COL11A1 Transcriptional Coupling as a Candidate Therapeutic Target in Colorectal Cancer: Integrative
Yasemin Başbınar1, Ömer Akgüller2,3, Asım Leblebici4
1Department of Translational Oncology, Oncology Institute, Dokuz Eylul University, Izmir 35340, Turkey.
Discoidin domain receptor 2 (DDR2) drives colorectal cancer progression by strengthening transcriptional coupling with COL11A1. This mechanism enhances collagen deposition and matrix remodeling, offering new therapeutic targets beyond receptor abundance.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Extracellular matrix (ECM) remodeling is crucial in colorectal cancer (CRC) progression.
- Transcriptional regulation of ECM components and matrix metalloproteinases in CRC is not fully understood.
Purpose of the Study:
- To investigate discoidin domain receptor (DDR)-mediated transcriptional networks in colorectal tumorigenesis.
- To elucidate the role of DDR1 and DDR2 in coordinating ECM remodeling during CRC progression.
Main Methods:
- Integrated computational analysis of 680 samples across normal, adenoma, and carcinoma stages.
- Stage-stratified correlation analysis of pathway genes and deep neural network classification.
- SHAP analysis to identify key gene interactions for cancer classification.
Main Results:
- DDR2 showed significantly strengthened correlations with pathway genes from normal to carcinoma, unlike DDR1.
- DDR2-COL11A1 coupling intensified dramatically in carcinoma, with increased COL11A1 expression.
- Pathway activation occurred despite stable DDR2 expression, highlighting enhanced transcriptional coupling efficiency.
- Deep neural networks achieved 93.14% accuracy in distinguishing CRC stages, with DDR2-COL11A1 identified as a key interaction.
Conclusions:
- DDR2-specific transcriptional coupling is a critical mechanism in colorectal cancer progression.
- COL11A1 is a key downstream target regulated by DDR2-mediated coupling.
- Therapeutic strategies targeting coupling efficiency, not just receptor abundance, may be beneficial for CRC treatment.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes